TORONTO, Oct. 13, 2025 /PRNewswire/ -- Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its wholly ...

Researchers created a nanoparticle-stem cell technology that greatly enhances 3D bone regeneration, advancing treatment for fractures and regenerative medicine. (Nanowerk News) A research team in ...

MIAMI, July 21, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, rare pediatric ...

Longeveron Inc., a biotechnology company focused on regenerative medicine, has licensed a US patent from the University of Miami aimed at developing cardiomyogenic precursor cells from pluripotent ...

CAMBRIDGE, England & EDINBURGH, Scotland & ALDERLEY PARK, England--(BUSINESS WIRE)--Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell technology provider for drug discovery has signed an ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Garuda Therapeutics (Garuda), a company creating off-the-shelf, durable blood stem cell-based cellular therapies, today announced a $62 million Series B financing ...

The researchers' success in direct reprogramming of mouse fibroblasts into alveolar epithelial-like cells may lead to new treatments for serious lung diseases. Researchers in Japan have successfully ...

Researchers in Japan have successfully generated lung cells similar to alveolar epithelial type 2 (AT2) cells from mouse embryonic fibroblasts without using stem cell technology. The AT2-like cells ...

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus. In this half-day virtual summit, a series of presentations ...

Researchers at Karolinska Institutet and KTH Royal Institute of Technology in Sweden have developed an improved method for ...